Form 4: BioLife Solutions HR Chief Sells Shares to Cover Tax Obligations
Insider Transaction Report
BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 235 shares of common stock for $23.7 per share to satisfy tax withholding obligations related to restricted stock vesting.
Summary
- Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
- The transaction involved the disposition of 235 shares of common stock.
- The shares were sold at a price of $23.7 per share.
- The sale occurred on June 10, 2025.
- This sale was executed pursuant to a Rule 10b5-1(c) trading plan, which was adopted by Ms. Aebersold on March 8, 2024.
- The purpose of the sale was to satisfy tax withholding obligations in connection with the vesting of restricted stock.
- Following this transaction, Ms. Aebersold beneficially owns 79,432 shares of BioLife Solutions common stock.
Sentiment
Score: 5
Explanation: The transaction is a routine, pre-planned sale to cover tax obligations upon restricted stock vesting and does not indicate a change in management's sentiment towards the company's prospects.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Management Comments
- The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Industry Context
This SEC Form 4 filing details a routine insider transaction for tax purposes and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: The sale is a routine, non-discretionary transaction for tax purposes and is unlikely to have a significant impact on shareholder sentiment or the company's valuation.
Key Dates
| Date | Description |
|---|---|
| 03-08-2024 | Date Rule 10b5-1(c) trading plan was adopted by Sarah Aebersold. |
| 06/10/2025 | Date of transaction (sale of common stock). |
| 06/12/2025 | Date the Form 4 filing was signed. |
Keywords
BioLife Solutions, BLFS, Form 4, insider trading, stock sale, tax withholding, restricted stock, Rule 10b5-1, Sarah Aebersold, Chief Human Resources Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.